The actinomycetes produce antibiotics as well as spore pigments during their life cycle by using Type II polyketide synthases (PKSs). Each PKS minimally consists of a ketosynthase heterodimer and an acyl carrier protein.
the R1128 initiation module and either spore pigment elongation module were observed. In contrast, when an equivalent C 24 ketosynthase heterodimer from the pradimicin ( pms) PKS was recombined with the R1128 initiation module, the engineered host was able to afford the expected products of the bimodular PKS. This observation suggested that there may be a fundamental incompatibility between PKS components from antibiotic and spore pigment pathways. Here, we test this hypothesis via a series of in vitro assays utilizing purified PKS proteins from different antibiotic and spore pigment pathways.
Although previous studies had shown that acyl carrier proteins (ACPs) from antibiotic biosynthetic pathways could be interchanged in vivo [14] and in vitro [15] without significant kinetic penalties, we speculated that the observed lack of crosstalk between heterologous spore pigment and antibiotic PKS subunits was primarily due to their inability to engage in catalytically productive proteinprotein interactions. To test this hypothesis, we first investigated the properties of the ketosynthase-chain length factor (KS-CLF) heterodimer and ACP from the sch PKS, a representative dodecaketide synthase involved in spore pigment biosynthesis [8] . Purified sch KS-CLF was titrated in vitro with various ACPs (Fren N from frenolicin PKS, Zhu N from R1128 PKS, GraACP from granaticin PKS, WhiE ACP from whiE PKS, and Pms ACP from pradimicin PKS) [11, 15, 16] . Assays were performed at 30°C in 10 ml of reaction buffer containing 10% glycerol as previously described [15] . With 2 mM of the KS-CLF heterodimer, 0.5 mM malonyl-CoA : ACP transacylase (MAT), and 30 mM of different holo-ACPs in each reaction, the reaction was initiated by adding 2 mM 14 C-malonyl-CoA and quenched by adding 10 m l 12.5% SDS after 30 minutes. For comparison, act and tcm KS-CLFs were also assayed along with sch KS-CLF. Each quenched mixture was extracted with ethyl acetate and analyzed by thin-layer chromatography (TLC). The amount of product accumulated at the end of the reaction is shown in Fig. 2 , and the kinetic parameters associated with each biosynthetic reaction are reported in Table 1 . The identity of the product of each reaction mixture was verified by comparison with authentic standards of SEK4/4b, SEK15/15b, and TW93c/93d isolated from appropriate recombinant cell lines [11, 13, 17] (Fig. 1) .
Our data revealed that the sch KS-CLF could synthesize polyketide in conjunction with the WhiE ACP but not any other heterologous ACP from antibiotic biosynthetic pathways, including the fren, gra, dps, and R1128 PKSs (Fig. 2) . The absolute rate of dodecaketide synthesis in vitro by the sch KS-CLF outfitted with the WhiE ACP was Actinorhodin, tetracenomycin C, and pradimicin A are antibiotics biosynthesized by natural polyketide synthases. SEK-compounds and TW-compounds are engineered polyketides biosynthesized from reconstituted antibiotic and spore pigments producing PKSs, respectively.
comparable to the rate of octaketide and decaketide synthesis by the act and tcm KS-CLF, respectively (Table  1) . Thus, it appears that spore pigment KS-CLF heterodimers have exceptionally high specificity for ACPs from spore pigment pathways. In contrast, the act and tcm KS-CLFs were able to interact with the WhiE ACP fruitfully, producing the expected octaketides (SEK4 and SEK4b) and decaketides (SEK15 and SEK15b), respectively. Since the rate of malonylation of holo-ACP by MAT is much faster than that of condensation of the malonyl-ACP by KS/CLF [15] , the MAT catalyzed reaction is unlikely to be the bottleneck in the above assay.
To rule out the possibility that chain length differences are responsible for the above observations, we extended these findings by assaying purified pms KS-CLF. The pms KS-CLF was cloned from Actinomadura hibisca [16] , expressed in S. coelicolor and purified as described for the tcm KS-CLF [14] to Ͼ80% homogeneity. Consistent with in vivo observations [13] , the purified pms KS-CLF synthesized the expected dodecaketides at wild-type or near wild-type rates in the presence of either heterologous antibiotic or spore pigment ACPs (Table 1) .
At first glance our findings may appear somewhat contradictory with in vivo results of Yu and Hopwood [7] . These investigators reported that, not only could the whiE ACP gene complement a lesion in the act ACP gene to yield actinorhodin, but the act ACP gene could also partially complement a mutant whiE ACP gene to induce pale grey pigmentation of spores. The precise reasons for this difference are unclear. Perhaps it reflects a somewhat relaxed ACP specificity of the whiE KS-CLF as compared to the sch KS-CLF. This is unlikely because experiments in our own laboratory involving co-expression of genes encoding the whiE KS-CLF and either ACP from the R1128 PKS yielded no polyketide product (unpublished results). Alternatively, Yu and Hopwood's observation may not reflect true complementation, rather the spores may have appeared pale grey due to diffusion of a small amount of actinorhodin from the substrate mycelium into spores.
(A similar pale grey color was also observed when the act KS-CLF was used to complement a mutant whiE KS-CLF.) Further work will be required to understand the apparent partial complementation of the whiE spore pigment pathway in vivo by the act ACP.
In conclusion, we have uncovered a fundamental incompatibility at the level of protein-protein interactions between antibiotic producing PKSs and spore pigment producing PKSs. This finding may contribute to understand the biochemical logic of PKS specificity during contemporaneous antibiotic and spore pigment synthesis in the life cycle of an actinomycete bacterium. It could also pave the way to engineer new types of "hybrid" polyketides by rationally combining spore pigment and antibiotic biosynthetic pathways.
